<DOC>
	<DOCNO>NCT01914432</DOCNO>
	<brief_summary>To evaluate efficacy safety YH16410 versus rosuvastatin telmisartan monotherapies patient hypertension hyperlipidemia</brief_summary>
	<brief_title>Efficacy Safety Study YH16410 Versus Rosuvastatin Telmisartan Monotherapies Patients With Hypertension Hyperlipidemia</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Signed Informed Consent Men woman â‰¥ 19 year age Subject one 3 condition classify Cardiovascular Risk Factors , 10Year Risk , Blood Pressure , LDLC , TG , Coronary Artery Disease Equivalent Females pregnant , breastfeeding , childbearing potential , unwilling practice adequate contraception throughout study . Other exclusion apply</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>